IRF6 controls Epstein-Barr virus (EBV) lytic reactivation and differentiation in EBV-infected epithelial cells
Data files
Jul 07, 2026 version files 23.67 MB
-
Blot_Key.ods
18.95 KB
-
README.md
889 B
-
Uncropped_blots_from_IRF6_paper.pdf
23.65 MB
Abstract
Latent Epstein-Barr virus (EBV) infection promotes undifferentiated nasopharyngeal carcinoma (NPC) and gastric carcinoma (GC), while EBV infection of normal differentiated oropharyngeal epithelial cells is lytic and kills the cell. Establishment of viral latency within epithelial cells is likely essential for the development of EBV-induced NPCs and GCs, but the mechanism(s) by which EBV latency is maintained in epithelial cells are not fully understood. Here we demonstrate that the cellular tumor suppressor protein IRF6, a master regulator of squamous cell epithelial cell differentiation, plays a critical role in promoting TPA-induced lytic EBV reactivation in vitro in both EBV-infected NPC cells and EBV-infected GC cells. Using a telomerase-immortalized normal oral keratinocyte cell line (NOKs) model which retains the ability to differentiate in response to TPA treatment, we show that TPA-induced lytic EBV reactivation requires the PKCδ-RIPK4-IRF6 signaling pathway. RIPK4 is a PKCδ (PRKCD)-activated cellular S/T kinase that phosphorylates and activates the IRF6 transcription factor. We demonstrate that inhibition of PKCδ, RIPK4 or IRF6 expression is sufficient to suppress TPA-induced epithelial cell differentiation, as well as lytic EBV reactivation, in NOKs. Furthermore, we find that latent EBV infection in NOKs inhibits the expression of IRF6. Importantly, we show that inducible expression of a constitutively active (phospho-mimetic) IRF6 mutant is sufficient to activate the lytic form of EBV infection in both EBV-infected NOKs and EBV-infected SNU719 GC cells. Finally, we demonstrate that the ability of constitutively active IRF6 to promote lytic EBV infection in NOKs is at least partially mediated by IRF6-induced expression of the BLIMP1 transcription factor, which we previously showed synergistically activates expression of the two EBV immediate-early proteins, BZLF1 and BRLF1, in conjunction with KLF4. Thus, suppression of IRF6 expression may promote NPC and GC tumors by blocking lytic EBV reactivation and differentiation.
Dataset DOI: 10.5061/dryad.pvmcvdnzp
Description of the data and file structure
This dataset contains uncropped Western blots, microscopy images, and metadata relevant to:
Fogarty SA, Singh DR, Nelson SE, Calandranis ME, Zhang Y, Pawelski AS, et al. IRF6 controls Epstein-Barr virus (EBV) lytic reactivation and differentiation in EBV-infected epithelial cells. PLoS Pathog. 2025 Jun;21(6):e1013236. doi:10.1371/journal.ppat.1013236 PubMed PMID: 40569988; PubMed Central PMCID: PMC12200665.
Files
Uncropped_blots_from_IRF6_paper.pdf: This pdf file contains images of uncropped Western blots and microscopy images.
Blot_Key.ods: This spreadsheet contains a key for samples and abbreviations used in Uncropped_blots_from_IRF6_paper.pdf.
